SMS Pharmaceuticals
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
May 22 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
SMS PHARMACEUTICALS MARCH-QUARTER CONSOL NET PROFIT 327.1 MILLION RUPEES
SMS PHARMACEUTICALS MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 2.38 BILLION RUPEES
Source text: ID:nBSE6lxrRX
Further company coverage: SMSP.NS
(([email protected];))
May 22 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
SMS PHARMACEUTICALS MARCH-QUARTER CONSOL NET PROFIT 327.1 MILLION RUPEES
SMS PHARMACEUTICALS MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 2.38 BILLION RUPEES
Source text: ID:nBSE6lxrRX
Further company coverage: SMSP.NS
(([email protected];))
April 29 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
SMS PHARMACEUTICALS LTD - TAX DEMAND REDUCED TO 4 MILLION RUPEES FROM 71.9 MILLION RUPEES
Source text: [ID:]
Further company coverage: SMSP.NS
(([email protected];))
April 29 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
SMS PHARMACEUTICALS LTD - TAX DEMAND REDUCED TO 4 MILLION RUPEES FROM 71.9 MILLION RUPEES
Source text: [ID:]
Further company coverage: SMSP.NS
(([email protected];))
An alert on U.S.-based industrial services company SMS appointing two directors to its board was inadvertently tagged to an Indian drugmaker SMS Pharmaceuticals SMSP.NS, an unrelated entity and has been withdrawn.
There will be no substitute.
STORY_NUMBER: nTUA4PQXXQ
STORY_DATE: 26/02/2026
STORY_TIME: 02:00:10 PM GMT
An alert on U.S.-based industrial services company SMS appointing two directors to its board was inadvertently tagged to an Indian drugmaker SMS Pharmaceuticals SMSP.NS, an unrelated entity and has been withdrawn.
There will be no substitute.
STORY_NUMBER: nTUA4PQXXQ
STORY_DATE: 26/02/2026
STORY_TIME: 02:00:10 PM GMT
** Shares of SMS Pharmaceuticals SMSP.NS jump 7.4% to 248.48 rupees; set for best day since late-April
** The U.S. FDA concluded inspection at its Hyderabad facility in Telangana state with no observations
** Stock on track for busiest trading session in two months, volumes at 7.7x the 30-day avg
** Year-to-date, stock up 4%
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of SMS Pharmaceuticals SMSP.NS jump 7.4% to 248.48 rupees; set for best day since late-April
** The U.S. FDA concluded inspection at its Hyderabad facility in Telangana state with no observations
** Stock on track for busiest trading session in two months, volumes at 7.7x the 30-day avg
** Year-to-date, stock up 4%
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
Alerts on FalconPoint Partners acquiring U.S.-based industrial services business SMS were incorrectly tagged to SMS Pharmaceuticals SMSP.NS, an unrelated company, and have been withdrawn.
For the correct alert, click here.
STORY_NUMBER:nTUA6NX5T2
STORY_DATE:26/08/2025
STORY_TIME:01:00 PM GMT
Alerts on FalconPoint Partners acquiring U.S.-based industrial services business SMS were incorrectly tagged to SMS Pharmaceuticals SMSP.NS, an unrelated company, and have been withdrawn.
For the correct alert, click here.
STORY_NUMBER:nTUA6NX5T2
STORY_DATE:26/08/2025
STORY_TIME:01:00 PM GMT
June 27 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
SMS PHARMACEUTICALS LTD - INCREASES HOLDING IN SMS PEPTIDES TO 99.98%
SMS PHARMACEUTICALS LTD - COST OF ACQUISITION 30 MILLION RUPEES
Source text: ID:nBSE32TlBn
Further company coverage: SMSP.NS
(([email protected];))
June 27 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
SMS PHARMACEUTICALS LTD - INCREASES HOLDING IN SMS PEPTIDES TO 99.98%
SMS PHARMACEUTICALS LTD - COST OF ACQUISITION 30 MILLION RUPEES
Source text: ID:nBSE32TlBn
Further company coverage: SMSP.NS
(([email protected];))
** Shares of SMS Pharmaceuticals SMSP.NS jumps 5.2% to 252 rupees, on track for third straight session of gains
** Co says U.S. FDA concluded an inspection at its Gagillapur facility in Telangana state with no observations
** More than 300,000 shares traded, 3.1x its 30-day moving avg
** YTD, stock up 0.10%
(Reporting by Yagnoseni Das in Bengaluru)
(([email protected];))
** Shares of SMS Pharmaceuticals SMSP.NS jumps 5.2% to 252 rupees, on track for third straight session of gains
** Co says U.S. FDA concluded an inspection at its Gagillapur facility in Telangana state with no observations
** More than 300,000 shares traded, 3.1x its 30-day moving avg
** YTD, stock up 0.10%
(Reporting by Yagnoseni Das in Bengaluru)
(([email protected];))
June 25 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
COMPLETES USFDA INSPECTION AT CENTRAL LABORATORY ANALYTICAL SERVICES
USFDA INSPECTION CONCLUDES WITH ZERO FORM 483 OBSERVATIONS
Source text: ID:nNSEbttpLK
Further company coverage: SMSP.NS
(([email protected];;))
June 25 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
COMPLETES USFDA INSPECTION AT CENTRAL LABORATORY ANALYTICAL SERVICES
USFDA INSPECTION CONCLUDES WITH ZERO FORM 483 OBSERVATIONS
Source text: ID:nNSEbttpLK
Further company coverage: SMSP.NS
(([email protected];;))
Oct 1 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
RECEIVES EDQM CERTIFICATION TO SUPPLY IBUPROFEN IN EUROPE
Source text for Eikon: ID:nNSE14Q7HP
Further company coverage: SMSP.NS
(([email protected];;))
Oct 1 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
RECEIVES EDQM CERTIFICATION TO SUPPLY IBUPROFEN IN EUROPE
Source text for Eikon: ID:nNSE14Q7HP
Further company coverage: SMSP.NS
(([email protected];;))
Aug 5 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
SMS PHARMACEUTICALS JUNE-QUARTER CONSOL NET PAT 163.7 MILLION RUPEES
SMS PHARMACEUTICALS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.64 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: SMSP.NS
(([email protected];))
Aug 5 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
SMS PHARMACEUTICALS JUNE-QUARTER CONSOL NET PAT 163.7 MILLION RUPEES
SMS PHARMACEUTICALS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.64 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: SMSP.NS
(([email protected];))
Feb 8 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
DEC-QUARTER CONSOL NET PROFIT 122.9 MILLION RUPEES VERSUS 52.8 MILLION RUPEES
DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 1.61 BILLION RUPEES VERSUS 1.49 BILLION RUPEES
APPROVED RAISING OF FUNDS THROUGH ISSUE OF CONVERTIBLE EQUITY WARRANTS UP TO 1.14 BILLION RUPEES
Source text for Eikon: ID:nBSE77lJkx
Further company coverage: SMSP.NS
(([email protected];))
Feb 8 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
DEC-QUARTER CONSOL NET PROFIT 122.9 MILLION RUPEES VERSUS 52.8 MILLION RUPEES
DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 1.61 BILLION RUPEES VERSUS 1.49 BILLION RUPEES
APPROVED RAISING OF FUNDS THROUGH ISSUE OF CONVERTIBLE EQUITY WARRANTS UP TO 1.14 BILLION RUPEES
Source text for Eikon: ID:nBSE77lJkx
Further company coverage: SMSP.NS
(([email protected];))
** Shares of SMS Pharmaceuticals SMSP.NS up as much as 7.9% to 130.65 rupees, touching their highest level since Sept. 4
** Stock posts biggest intraday pct gain since Aug. 24; on track for a fifth consecutive sessions of gains, if trends hold
** The pharmaceutical manufacturing co reported a more than 16-fold surge in profit to 120.5 mln rupees ($1.45 million) from 7.3 mln rupees a year earlier
** Revenue from operations rose 4.5% to 1.67 bln rupees
** More than 683,000 shares change hands by 1:33 p.m. IST, 12.8x its 30-day avg
** Stock currently up 3.4%, bumping YTD gains to 51.03%
($1 = 83.2700 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
** Shares of SMS Pharmaceuticals SMSP.NS up as much as 7.9% to 130.65 rupees, touching their highest level since Sept. 4
** Stock posts biggest intraday pct gain since Aug. 24; on track for a fifth consecutive sessions of gains, if trends hold
** The pharmaceutical manufacturing co reported a more than 16-fold surge in profit to 120.5 mln rupees ($1.45 million) from 7.3 mln rupees a year earlier
** Revenue from operations rose 4.5% to 1.67 bln rupees
** More than 683,000 shares change hands by 1:33 p.m. IST, 12.8x its 30-day avg
** Stock currently up 3.4%, bumping YTD gains to 51.03%
($1 = 83.2700 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
May 24 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
INDIA'S SMS PHARMACEUTICALS LTD MARCH-QUARTER CONSOL NET PAT 80.7 MILLION RUPEES VERSUS PROFIT 89 MILLION RUPEES
SMS PHARMACEUTICALS LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.49 BILLION RUPEES VERSUS 609.2 MILLION RUPEES
Source text for Eikon: ID:nBSEbTmNmR
Further company coverage: SMSP.NS
(([email protected];))
May 24 (Reuters) - SMS Pharmaceuticals Ltd SMSP.NS:
INDIA'S SMS PHARMACEUTICALS LTD MARCH-QUARTER CONSOL NET PAT 80.7 MILLION RUPEES VERSUS PROFIT 89 MILLION RUPEES
SMS PHARMACEUTICALS LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.49 BILLION RUPEES VERSUS 609.2 MILLION RUPEES
Source text for Eikon: ID:nBSEbTmNmR
Further company coverage: SMSP.NS
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does SMS Pharmaceuticals do?
SMS Pharmaceuticals Ltd is a leading Indian pharmaceutical manufacturer with state-of-the-art facilities meeting international standards. The company received export house status in 1997-98 and serves a growing global and local customer base.
Who are the competitors of SMS Pharmaceuticals?
SMS Pharmaceuticals major competitors are Aarti Drugs, IOL Chem & Pharma, Solara Active Pharma, Morepen Laboratories, NGL Fine-Chem, Hester Biosciences, Bajaj Healthcare. Market Cap of SMS Pharmaceuticals is ₹3,510 Crs. While the median market cap of its peers are ₹2,750 Crs.
Is SMS Pharmaceuticals financially stable compared to its competitors?
SMS Pharmaceuticals seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does SMS Pharmaceuticals pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. SMS Pharmaceuticals latest dividend payout ratio is 5.13% and 3yr average dividend payout ratio is 5.96%
How has SMS Pharmaceuticals allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory
How strong is SMS Pharmaceuticals balance sheet?
Balance sheet of SMS Pharmaceuticals is strong. But short term working capital might become an issue for this company.
Is the profitablity of SMS Pharmaceuticals improving?
Yes, profit is increasing. The profit of SMS Pharmaceuticals is ₹88 Crs for TTM, ₹69.14 Crs for Mar 2025 and ₹49.83 Crs for Mar 2024.
Is the debt of SMS Pharmaceuticals increasing or decreasing?
Yes, The net debt of SMS Pharmaceuticals is increasing. Latest net debt of SMS Pharmaceuticals is ₹319 Crs as of Mar-26. This is greater than Mar-25 when it was ₹228 Crs.
Is SMS Pharmaceuticals stock expensive?
Yes, SMS Pharmaceuticals is expensive. Latest PE of SMS Pharmaceuticals is 34.42, while 3 year average PE is 27.6. Also latest EV/EBITDA of SMS Pharmaceuticals is 22.36 while 3yr average is 19.49.
Has the share price of SMS Pharmaceuticals grown faster than its competition?
SMS Pharmaceuticals has given better returns compared to its competitors. SMS Pharmaceuticals has grown at ~29.76% over the last 7yrs while peers have grown at a median rate of 16.09%
Is the promoter bullish about SMS Pharmaceuticals?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in SMS Pharmaceuticals is 68.07% and last quarter promoter holding is 68.07%.
Are mutual funds buying/selling SMS Pharmaceuticals?
The mutual fund holding of SMS Pharmaceuticals is decreasing. The current mutual fund holding in SMS Pharmaceuticals is 2.96% while previous quarter holding is 3.21%.